Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T16:34:33.291Z Has data issue: false hasContentIssue false

From the laboratory to the clinic: advancing helminthic therapy for type 2 diabetes

Published online by Cambridge University Press:  25 July 2025

Y. Zhu
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
X. Fei
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
R. Wang
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
J. Wang
Affiliation:
School of Basic Medicine and Forensic Medicine, Hangzhou Medical College , Hangzhou, China
M. Liu
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
Y. Zhang
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
X. Li
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
J. Xu
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
Q. Zhao
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
X. Zhang
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
K. Chen
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, China
H. Li*
Affiliation:
Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University , Hangzhou, ChinaOcean College, Beibu Gulf University, Qinzhou, China
*
Corresponding author: H. Li; Email: hongyu88926@zjsru.edu.cn
Rights & Permissions [Opens in a new window]

Abstract

The interaction of helminth infections with type 2 diabetes (T2D) has been a major area of research in the past few years. This paper, therefore, focuses on the systematic review of the effects of helminthic infections on metabolism and immune regulation related to T2D, with mechanisms through which both direct and indirect effects are mediated. Specifically, the possible therapeutic role of helminths in T2D management, probably mediated through the modulation of host metabolic pathways and immune responses, is of special interest. This paper discusses the current possibilities for translating helminth therapy from basic laboratory research to clinical application, as well as existing and future challenges. Although preliminary studies suggest the potential for helminth therapy for T2D patients, their safety and efficacy still need to be confirmed by larger-scale clinical studies.

Information

Type
Review Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1.Number of people with diabetes worldwide and per IDF Region in 2021–2045 (20–79 years).Source: International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org.

Figure 1

Figure 2.The multifactorial pathogenesis of T2D. T2D is primarily a metabolic disorder characterized by IR and β-cell dysfunction. This condition is caused by genetic predispositions and environmental factors, which disrupt insulin signalling pathways. Diets rich in fats and sugars, coupled with insufficient physical activity, alterations in the gut microbiome, and pharmacological interactions, contribute to reduced insulin receptor sensitivity in adipose and muscle tissues. This resistance impairs the functionality and expression of insulin-dependent glucose transporters, such as glucose transporter type 4 (GLUT4), subsequently hindering glucose uptake and utilisation. Furthermore, in response to persistent IR, an increase in insulin production is compelled in pancreatic β-cells, a demand that may ultimately lead to β-cell exhaustion or apoptosis. Concurrently, chronic inflammation exacerbates this condition by modulating the cytokine network, including IL-6, TNF-α, and IL-1β, which disrupts insulin signalling and affects immune cell function, notably altering the balance between pro-inflammatory and anti-inflammatory T-cells.

Figure 2

Figure 3.The interaction between intestinal worms and the microbiota. Helminths alter the host’s glucose absorption mechanisms by modifying the expression of specific glucose transporter isoforms in the intestinal epithelial cells. Concurrently, helminth infections stimulate a Th2-type immune response, leading to significant changes in the gut microbiota’s composition and functional dynamics. These immunological shifts are facilitated by an increase in the production of SCFAs by the microbiota, subsequently diminishing nutrient absorption by the host. Additionally, the altered microbiota impacts the enteric nervous system, affecting neurons, sensory nerves, and interneurons. This interaction extends to influence systemic neurotransmitter levels, including gamma-aminobutyric acid, serotonin, and dopamine, further illustrating the extensive biochemical interactions between helminths, the gut microbiota, and host physiology.

Figure 3

Figure 4.Parasitic infections induce complex interactions between intestinal epithelial layers and immune cells to regulate the host immune response finely. In the intestinal mucosa, host cells instigate the activation of specific immune cell subsets via antigen presentation and cytokine release. A, Notably, antigens are relayed to dendritic cells (DCs) through the recognition mechanisms of Peyer’s patches. B, The immune response modulation following an infection in the mesenteric lymph nodes encompasses interactions among T cell subsets, including the activation and equilibrium of Th1, Th2, Th17, and Treg cells. C, Within the intestinal muscular layer, immune cells such as eosinophils and MCs react to parasitic infections by secreting anti-inflammatory mediators like IL-4, which notably influences the shift of MΦ towards an M2 phenotype. D, Additionally, the eggs of helminths exhibit inherent capabilities for immune evasion. This overview outlines immune cells’ complex interplay and strategic responses to maintain intestinal integrity and combat parasitic threats.

Figure 4

Figure 5.Advances in research on helminthic therapy. Initial epidemiological studies identified a negative correlation between helminth infection rates and T2D. The OR indicated in the data figure from the study by Chen et al. (2013) (doi:10.1210/jc.2012-2517) illustrates the strength and direction of this association, offering empirical support for hypotheses evaluating the effects of schistosomiasis infections on such metabolic conditions. Subsequent studies utilise methods like blood monitoring and deworming treatments to inversely investigate the influence of parasites on the clinical markers of T2D. Progressively, more precise controlled trials are being initiated.